Trial Summary
The trial information does not specify whether you need to stop taking your current medications. It seems likely that you can continue them, as there are no exclusion criteria related to medication use.
Research shows that Acceptance-Based Behavior Therapy (ABBT) can help improve medication adherence in people with HIV by addressing avoidance behaviors. Additionally, Acceptance and Commitment Therapy (ACT), a similar approach, has been effective for anxiety and depression, suggesting ABBT may also be beneficial for mental health issues in the LGBTQ+ community.
12345Research on Acceptance-Based Behavior Therapy (ABBT) and its related forms, like Acceptance and Commitment Therapy (ACT), suggests that these therapies are generally safe for humans. They have been used in various studies for conditions like anxiety, depression, and HIV medication adherence, with no significant safety concerns reported.
12467Acceptance-Based Behavior Therapy (ABBT) is unique because it focuses on improving social support and reducing mental health symptoms by promoting acceptance and commitment to personal values, which is particularly beneficial for LGBTQ+ individuals who may experience heightened anxiety and depression due to minority stress and social isolation.
89101112Eligibility Criteria
This trial is for English-speaking adults over 18 who identify as LGBTQ+ and are experiencing mild or greater anxiety and/or depression. Participants must be seeking any clinical care at the recruitment clinic.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive a 2-session Acceptance-Based Behavioral Therapy (ABBT) delivered remotely or in-person, or Treatment-as-Usual (TAU)
Follow-up
Participants are monitored for anxiety and depressive symptoms using various scales